1. Home
  2. MYNZ
  3. MYNZ News

Latest Mainz Biomed N.V. (MYNZ) News on July 27, 2025

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
MYNZ

GlobeNewswire

a month ago

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

Mainz begins next phase of project to develop pancreatic cancer blood test
MYNZ

Medical Device Network

2 months ago

Mainz begins next phase of project to develop pancreatic cancer blood test

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
MYNZ

GlobeNewswire

2 months ago

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

7 Summer Side Hustles That Can Pay $1,000 a Week or More
MYNZ

GOBankingRates

2 months ago

7 Summer Side Hustles That Can Pay $1,000 a Week or More

Will Tesla have to play catch up to Waymo's robotaxis?
MYNZ

Yahoo Finance Video

2 months ago

Will Tesla have to play catch up to Waymo's robotaxis?

Why Scott Bessent wants to make it easier for banks to own Treasurys
MYNZ

Yahoo Finance

2 months ago

Why Scott Bessent wants to make it easier for banks to own Treasurys

When are people too old to do their jobs?
MYNZ

The Guardian

2 months ago

When are people too old to do their jobs?

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
MYNZ

GlobeNewswire

2 months ago

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry

MYNZ

GlobeNewswire

2 months ago

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population
MYNZ

PR Newswire

2 months ago

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

Statement by Minister Guilbeault on Portuguese Heritage Month
MYNZ

CNW Group

2 months ago

Statement by Minister Guilbeault on Portuguese Heritage Month

Will AI Empower the PR Industry or Create Endless Seas of Spam?
MYNZ

The Wall Street Journal

2 months ago

Will AI Empower the PR Industry or Create Endless Seas of Spam?

Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants
MYNZ

GlobeNewswire

2 months ago

Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants

MYNZ

MT Newswires

2 months ago

Top Premarket Decliners

Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
MYNZ

GlobeNewswire

2 months ago

Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study

Mainz Biomed Enters into Technology Partnership with EDX Medical Group
MYNZ

GlobeNewswire

3 months ago

Mainz Biomed Enters into Technology Partnership with EDX Medical Group

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
MYNZ

GlobeNewswire

3 months ago

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
MYNZ

GlobeNewswire

4 months ago

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update

Mainz enrols first subject in study to evaluate colorectal cancer test
MYNZ

Medical Device Network

4 months ago

Mainz enrols first subject in study to evaluate colorectal cancer test

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
MYNZ

GlobeNewswire

4 months ago

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study

MYNZ

MT Newswires

4 months ago

Mainz Biomed, Liquid Biosciences Partner on Blood-Based Test for Pancreatic Cancer

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
MYNZ

GlobeNewswire

4 months ago

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
MYNZ

GlobeNewswire

5 months ago

Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention

Mainz Biomed Expands into Switzerland with labor team w
MYNZ

GlobeNewswire

5 months ago

Mainz Biomed Expands into Switzerland with labor team w

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month
MYNZ

GlobeNewswire

6 months ago

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
MYNZ

GlobeNewswire

6 months ago

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements

Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population
MYNZ

GlobeNewswire

6 months ago

Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population

Mainz Biomed partners with Quest for colorectal cancer screening test
MYNZ

Medical Device Network

7 months ago

Mainz Biomed partners with Quest for colorectal cancer screening test

MYNZ

MT Newswires

7 months ago

Mainz Biomed Partners With Quest Diagnostics for Colorectal Cancer Screening Test

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
MYNZ

GlobeNewswire

7 months ago

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering
MYNZ

GlobeNewswire

7 months ago

Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering

Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules
MYNZ

GlobeNewswire

7 months ago

Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules

MYNZ

MT Newswires

8 months ago

Mainz Biomed to Implement 1-for-40 Reverse Stock Split

Mainz Biomed Announces Stock Split
MYNZ

GlobeNewswire

8 months ago

Mainz Biomed Announces Stock Split

The Oncology Bet Is Already Paying Off For Pfizer
MYNZ

Benzinga

8 months ago

The Oncology Bet Is Already Paying Off For Pfizer

MYNZ

MT Newswires

8 months ago

Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
MYNZ

GlobeNewswire

8 months ago

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets

Mainz Biomed restructured operations, implemented cost reductions
MYNZ

TipRanks

9 months ago

Mainz Biomed restructured operations, implemented cost reductions

Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
MYNZ

GlobeNewswire

9 months ago

Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update

Mainz Biomed Secures Additional $1.5M Funding
MYNZ

TipRanks

10 months ago

Mainz Biomed Secures Additional $1.5M Funding

Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version
MYNZ

GlobeNewswire

10 months ago

Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version

The Covid Era Tech Promises To Reinvent Cancer Treatment
MYNZ

Benzinga

10 months ago

The Covid Era Tech Promises To Reinvent Cancer Treatment

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
MYNZ

GlobeNewswire

10 months ago

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025

Pfizer Advances On Its Cancer Journey
MYNZ

Benzinga

10 months ago

Pfizer Advances On Its Cancer Journey

Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador
MYNZ

GlobeNewswire

10 months ago

Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador

MYNZ

MT Newswires

a year ago

Mainz Biomed Expands AI Collaboration With Liquid Biosciences to Include Pancreatic Cancer Test

Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert

Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
MYNZ

Benzinga

a year ago

Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer

Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience

Mainz Biomed seeks FDA breakthrough device status for colorectal cancer test
MYNZ

Medical Device Network

a year ago

Mainz Biomed seeks FDA breakthrough device status for colorectal cancer test

MYNZ

MT Newswires

a year ago

Top Premarket Gainers

Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
MYNZ

Benzinga

a year ago

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment

Mainz Biomed Provides Half Year 2024 Corporate Update
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Provides Half Year 2024 Corporate Update

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares
MYNZ

GuruFocus.com

a year ago

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares

ADM Animal Nutrition Expands Recall to Include Additional Lots of Various Feed Products
MYNZ

Business Wire

a year ago

ADM Animal Nutrition Expands Recall to Include Additional Lots of Various Feed Products

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares
MYNZ

GuruFocus.com

a year ago

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares

Factbox-Here's everything Apple announced at WWDC
MYNZ

Reuters

a year ago

Factbox-Here's everything Apple announced at WWDC

Elon Musk's Tesla pay package: More shareholders speak out
MYNZ

Yahoo Finance Video

a year ago

Elon Musk's Tesla pay package: More shareholders speak out

Cargojet enters charter deal for Chinese e-commerce
MYNZ

FreightWaves

a year ago

Cargojet enters charter deal for Chinese e-commerce

AVENUE 8 DOUBLES DOWN ON GENERATIVE AI, SHIFTS FOCUS TO SIDEKICK PLATFORM FOR REAL ESTATE AGENTS
MYNZ

PR Newswire

a year ago

AVENUE 8 DOUBLES DOWN ON GENERATIVE AI, SHIFTS FOCUS TO SIDEKICK PLATFORM FOR REAL ESTATE AGENTS

Enghouse Releases Second Quarter Results
MYNZ

CNW Group

a year ago

Enghouse Releases Second Quarter Results

Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
MYNZ

Benzinga

a year ago

Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon

Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024

Mainz Biomed Reports Results of 2024 Annual General Meeting
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Reports Results of 2024 Annual General Meeting

Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
MYNZ

GlobeNewswire

a year ago

Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting

Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
MYNZ

Benzinga

a year ago

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
MYNZ

GlobeNewswire

a year ago

Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.

mRNA Is Promising A Breakthrough In Fighting Cancer
MYNZ

Benzinga

a year ago

mRNA Is Promising A Breakthrough In Fighting Cancer

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic

The Pharmaceutical Industry Finds Itself At A Historical Crossroads
MYNZ

Benzinga

a year ago

The Pharmaceutical Industry Finds Itself At A Historical Crossroads

Mainz Biomed Reports Full Year 2023 Financial Results
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Reports Full Year 2023 Financial Results

Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment

Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
MYNZ

GlobeNewswire

a year ago

Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations

What Makes Mainz Biomed NV (MYNZ) a New Buy Stock
MYNZ

Zacks

a year ago

What Makes Mainz Biomed NV (MYNZ) a New Buy Stock

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic

Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening
MYNZ

Benzinga

a year ago

Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening

Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
MYNZ

GlobeNewswire

a year ago

Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community

Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
MYNZ

Benzinga

a year ago

Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment

Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®

Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy

2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front
MYNZ

Benzinga

a year ago

2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front

Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany

Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
MYNZ

Benzinga

a year ago

Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle

AVROBIO and Tectonic Therapeutic Announce Merger
MYNZ

Business Wire

a year ago

AVROBIO and Tectonic Therapeutic Announce Merger

MAGYAR BANCORP, INC. ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND DECLARES DIVIDEND
MYNZ

PR Newswire

2 years ago

MAGYAR BANCORP, INC. ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND DECLARES DIVIDEND

Chuck Royce Increases Stake in Express, Inc.
MYNZ

GuruFocus.com

2 years ago

Chuck Royce Increases Stake in Express, Inc.

CORRECTION – Oak Valley Bancorp Reports 4th Quarter Results and Announces Cash Dividend
MYNZ

GlobeNewswire

2 years ago

CORRECTION – Oak Valley Bancorp Reports 4th Quarter Results and Announces Cash Dividend

D-Wave Names Kirstjen Nielsen, Former Secretary of Homeland Security, to Board of Directors
MYNZ

Business Wire

2 years ago

D-Wave Names Kirstjen Nielsen, Former Secretary of Homeland Security, to Board of Directors

Idaho Strategic to Participate in Upcoming Industry Events
MYNZ

ACCESSWIRE

2 years ago

Idaho Strategic to Participate in Upcoming Industry Events

Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
MYNZ

GlobeNewswire

2 years ago

Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints

A Look Back at Specialty Retail Stocks' Q3 Earnings: Petco (NASDAQ:WOOF) Vs The Rest Of The Pack
MYNZ

StockStory

2 years ago

A Look Back at Specialty Retail Stocks' Q3 Earnings: Petco (NASDAQ:WOOF) Vs The Rest Of The Pack

Euroseas Ltd. Announces Time Charter Contract for its Fuel-Efficient 2,800 teu Feeder Containership, M/V Tender Soul, to be delivered in February 2024
MYNZ

GlobeNewswire

2 years ago

Euroseas Ltd. Announces Time Charter Contract for its Fuel-Efficient 2,800 teu Feeder Containership, M/V Tender Soul, to be delivered in February 2024

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
MYNZ

GlobeNewswire

2 years ago

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium

AmpliTech Group Unveils AGTGSS Flagship Product, A Massive MIMO, 64T64R ORAN, CAT B Radio And Launches New AGTGSS Division Website
MYNZ

GlobeNewswire

2 years ago

AmpliTech Group Unveils AGTGSS Flagship Product, A Massive MIMO, 64T64R ORAN, CAT B Radio And Launches New AGTGSS Division Website

2024 Marks a New Era Of Pharmaceutical Innovation
MYNZ

Benzinga

2 years ago

2024 Marks a New Era Of Pharmaceutical Innovation

Mainz Biomed Provides Year-End Corporate Review 2023
MYNZ

GlobeNewswire

2 years ago

Mainz Biomed Provides Year-End Corporate Review 2023

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization
MYNZ

Benzinga

2 years ago

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

Share on Social Networks: